Clinical Trial Update: Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update discusses a phase 1/2 study of amifostine in combination with chemotherapy and radiation therapy for patients with advanced, unresect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer | Phase 1, Phase 2 | Status: UNKNOWN